0001104659-17-021482.txt : 20170404
0001104659-17-021482.hdr.sgml : 20170404
20170404191007
ACCESSION NUMBER: 0001104659-17-021482
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170401
FILED AS OF DATE: 20170404
DATE AS OF CHANGE: 20170404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ophthotech Corp.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
BUSINESS PHONE: 212-845-8200
MAIL ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SBLENDORIO GLENN
CENTRAL INDEX KEY: 0001277478
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 17740501
MAIL ADDRESS:
STREET 1: 3 TIMES SQAURE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
a4.xml
4
X0306
4
2017-04-01
0
0001410939
Ophthotech Corp.
OPHT
0001277478
SBLENDORIO GLENN
C/O OPHTHOTECH CORPORATION
ONE PENN PLAZA, 19TH FLOOR
NEW YORK
NY
10119
0
1
0
0
President, CFO and Treasurer
Common Stock
2017-04-01
4
M
0
18750
A
18960
D
Common Stock
2017-04-03
4
S
0
7388
3.56
D
11572
D
Restricted Stock Units
2017-04-01
4
M
0
18750
0.00
D
2026-03-31
Common Stock
18750
56250
D
Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
This total includes 210 shares acquired by the reporting person under the issuer's 2016 Employee Stock Purchase Plan on March 15, 2017.
Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the reporting person's minimum statutory withholding obligations with respect to the income recognized by the reporting person upon the vesting of the restricted stock units on April 1, 2017.
These shares were disposed of in multiple transactions on April 3, 2017 at actual sales prices ranging from $3.55 to $3.59 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
On April 1, 2016, the reporting person was granted an award of 75,000 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the issuer and the other terms and conditions under the issuer's 2013 Stock Incentive Plan.
/s/ Barbara Wood, as Attorney-in-Fact for Glenn Sblendorio
2017-04-04